Investigating the causes and treatment of high calcium levels from paraffin oil injections
Hypercalcemia After Cosmetic Paraffin Oil Injections: Unravelling Etiology, Pathogenesis and Potential Treatments
This study looks at the health issues caused by paraffin oil injections to see how they affect people and to help find new treatments for those problems.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 200 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Herlev Hospital Academic / other |
| Locations | 1 site (Copenhagen) |
| Trial ID | NCT04265599 on ClinicalTrials.gov |
What this trial studies
This observational study aims to characterize the granulomatous disease caused by intramuscular injections of paraffin oil, focusing on the pathogenesis and natural history of the condition. By understanding these aspects, the study seeks to lay the groundwork for identifying novel treatments that can be tested in future randomized clinical trials. The research will involve collecting data from patients who have previously received such injections to better understand the implications of paraffin oil on health.
Who should consider this trial
Good fit: Ideal candidates for this study are individuals who have previously received intramuscular injections of paraffin or other oils.
Not a fit: Patients who have not received intramuscular injections of paraffin or other oils may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to new treatment options for patients suffering from hypercalcemia and related conditions caused by paraffin oil injections.
How similar studies have performed: While this study explores a specific condition, similar observational studies have provided valuable insights into treatment pathways for related diseases, suggesting potential for success.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * previous intramuscular injection of paraffin or other oil Exclusion Criteria: * none
Where this trial is running
Copenhagen
- Herlev Hospital — Copenhagen, Denmark (Recruiting)
Study contacts
- Study coordinator: Ebbe Eldrup, DMSc
- Email: ebbe.eldrup@regionh.dk
- Phone: 800-045-3868
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.